Serotonin and 5-hydroxyindoleacetic acid are involved in the pathogenesis of COVID-19 in children

Abstract

Background. The new coronavirus infection COVID-19 is a pressing health problem around the world. This disease affects the respiratory, cardiovascular and other systems. The role of serotonin as one of the key factors in COVID-19 is discussed in the literature.

Aim. Determination of the concentration of serotonin and its metabolite 5-hydroxyindoleacetic acid in the blood serum of children in the acute period of COVID-19 for use as a diagnostic criterion for the severity of the disease.

Material and methods. A study that included 141 children aged 0 to 17 years was conducted: 92 patients hospitalized in a hospital with a diagnosis of COVID-19 without concomitant pathology made up the study group, 49 healthy children were included in the control group. The subjects were divided into two age groups: younger (0–2 years) and older (3–17 years). The groups of patients and children from the control group were comparable in age and gender. A study of the concentration of serotonin and its metabolite — 5-hydroxyindoleacetic acid — in the blood was carried out using high-performance liquid chromatography, and the results of laboratory and instrumental research methods (obtained from medical records) were evaluated. Based on the results of computed tomography, the proportion of involvement of the lung parenchyma in the pathological process was calculated: CT0 — absence of lung damage; CT1 — less than 25%; CT2 — 25–49%; CT3 — 50–74%; CT4 — more than 75%. Quantitative data were described using median (Me) and lower and upper quartiles (Q1–Q3). To analyze the data, the Pearson χ2 test, nonparametric Kruskal–Wallis and Mann–Whitney tests, as well as the ROC curve method were used. A correlation analysis was carried out using the Spearman coefficient and an assessment of the dependence of a quantitative variable on factors using the linear regression method.

Results. In children with COVID-19 aged 0–2 years, the concentration of serotonin (969.41 pmol/ml) in the blood serum was statistically significantly higher by 49.1 times, in the group of 3–17 years (637.87 pmol/ml) — by 24.5 times compared to age-matched controls (19.74 pmol/ml; p <0.001 and 26.0 pmol/ml; p <0.001, respectively). The concentration of 5-hydroxyindoleacetic acid in patients 0–2 years old (204.90 pmol/ml) was 4.7 times higher relative to healthy children (43.56 pmol/ml; p=0.003), and in the older age group (78.25 pmol/ml) — 2.4 times higher (32.65 pmol/ml; p=0.012), which suggests increased breakdown of serotonin under the influence of monoamine oxidase A. Maximum concentrations of serotonin in blood serum were detected in children aged 0–2 years (1808.79 pmol/ml) with damage to the lung parenchyma from 50 to 74% (grade 3 according to computed tomography). However, in children aged 3–17 years, the maximum concentrations of serotonin (2036.95 pmol/ml) were detected with lung damage ranging from 25 to 49% (grade 2 according to computed tomography). In patients with COVID-19, when the concentration of serotonin in the blood was above 1046.5 pmol/ml, grade 2–4 lung lesions were predicted according to computed tomography, sensitivity 62.5%, specificity 75%.

Conclusion. With COVID-19, a significant increase in the concentration of serotonin and 5-hydroxyindoleacetic acid in the blood was detected in children.

Keywords

serotonin / 5-HT / 5-hydroxyindoleacetic acid / 5-HIAA / children / COVID-19

References

[1] Zhao YH, Zhao L, Yang XC, Wang P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): A systematic review and meta-analysis. Rev Cardiovasc Med. 2021;22(1):159–165. DOI: 10.31083/j.rcm.2021.01.238.

[2] Akhmetova MZ, Tykezhanova GМ, Mindubaeva FА, Nigmatullina RR. Serotonin: Biological properties and its receptors. Bulletin Of The Karaganda University. Biology. Medicine. Geography Series. 2019;(2):71–79.

[3] Rieder M, Gauchel N, Bode C, Duerschmied D. Serotonin: A platelet hormone modulating cardiovascular disease. J Thromb Thrombolysis. 2021;52(1):42–47. DOI: 10.1007/s11239-020-02331-0.

[4] Aflyatumova GN, Nigmatullina RR, Sadykova DI, Chibireva MD, Fugetto F, Serra R. Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents. Vasc Health Risk Manag. 2018;14:213–223. DOI: 10.2147/VHRM.S170317.

[5] Tarbit E, Singh I, Peart JN, Bivol S, Rose'Meyer RB. Increased release of serotonin from rat primary isolated adult cardiac myofibroblasts. Sci Rep. 2021;11(1):20376. DOI: 10.1038/s41598-021-99632-y.-

[6] Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, Mahir W, Belayachi L, Belefquih B, Benouda A, Cheikh A, Langlois MA, Cherrah Y, Flamand L, Guessous F, Boilard E. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127(11):1404–1418. DOI: 10.1161/CIRCRESAHA.120.317703.

[7] Zaid Y, Guessous F, Puhm F, Elhamdani W, Chentoufi L, Morris AC, Cheikh A, Jalali F, Boilard E, Flamand L. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19. Blood Adv. 2021;5(3):635–639. DOI: 10.1182/bloodadvances.2020003513.

[8] Ha S, Jin B, Clemmensen B, Park P, Mahboob S, Gladwill V, Lovely FM, Gottfried-Blackmore A, Habtezion A, Verma S, Ro S. Serotonin is elevated in COVID-19-associated diarrhoea. Gut. 2021;70(10):2015–2017. DOI: 10.1136/gutjnl-2020-323542.

[9] Kanova M, Kohout P. Serotonin — its synthesis and roles in the healthy and the critically ill. Int J Mol Sci. 2021;22(9):4837. DOI: 10.3390/ijms22094837.

[10] Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (26.10.2020). https://static0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/%D0%9C%D0%A0_COVID-19_%28v.9%29.pdf (access date: 13.08.2023). (In Russ.)

[11] Временные методические рекомендации "Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)", версия 9 (26.10.2020). https://static0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/%D0%9C%D0%A0_COVID-19_%28v.9%29.pdf (дата обращения: 13.08.2023).

[12] Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, Balamuth FB, Blatz AM, Chiotos K, Fitzgerald JC, Giglia TM, Gollomp K, Odom John AR, Jasen C, Leng T, Petrosa W, Vella LA, Witmer C, Sullivan KE, Laskin BL, Hensley SE, Bassiri H, Behrens EM, Teachey DT. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4(23):6051–6063. DOI: 10.1182/bloodadvances.2020003471.

[13] Watts SW, Davis RP. 5-Hydroxtryptamine receptors in systemic hypertension: An arterial focus. Cardiovasc Ther. 2011;29(1):54–67. DOI: 10.1111/j.1755-5922.2010.00173.x.

[14] Sadykova DI, Nigmatullina RR, Aflyatumova GN. The role of serotonergic system in cardiovascular diseases development in children. Kazan Medical Journal. 2015;96(4):665–669. (In Russ.) DOI: 10.17750/KMJ2015-665.

[15] Садыкова Д.И., Нигматуллина Р.Р., Афлятумова Г.Н. Роль серотонинергической системы в развитии заболеваний сердца и сосудов у детей. Казанский медицинский журнал. 2015;96(4):665–669. DOI: 10.17750/KMJ2015-665.

[16] Sveshnikov DS, Kuchuk AV, Smirnov VM, Cherepanova GV. Serotonergic mechanisms of regulation of the systemic circulation vessels lumen. Kazan Medical Journal. 2016;97(1):89–94. (In Russ.) DOI: 10.17750/KMJ2016-89.

[17] Свешников Д.С., Кучук А.В., Смирнов В.М., Черепанова Г.В. Серотонинергические механизмы регуляции просвета сосудов большого круга кровообращения. Казанский медицинский журнал. 2016;97(1):89–94. DOI: 10.17750/KMJ2016-89.

[18] Monassier L, Maroteaux L. Serotonin and cardiovascular diseases. In: Serotonin: The mediator that spans evolution. Pilowsky PM, editor. Amsterdam: Elsevier, 2019. p. 203–238. DOI: 10.1016/b978-0-12-800050-2.00012-7.

Funding

Исследование выполнено за счёт гранта Российского научного фонда(№ 23-15-00417, https://rscf.ru/project/23-15-00417/)

RIGHTS & PERMISSIONS

Eco-Vector